News

Liverpool Heart and Chest awarded HIMSS stage 6

Liverpool Heart and Chest Hospital NHS FT (LHCH) has achieved the HIMSS (Health Information and Management System Society) Electronic Medical Record Adoption Model (EMRAM) Stage 6 rating.

The HIMSS EMRAM system, an international quality standard, measures the adoption and maturity of a health facility’s inpatient EMR (Endoscopic Mucosal Resection) capabilities from 0 to 7 – with Stage 7 being the highest possible rating.

Within the LHCH statement, the trust highlights that it has met Stage 6 of the HIMSS criteria owing to its establishment of clear goals in improving safety, minimising errors, and recognising the importance of healthcare IT.

Mark Pullan, Consultant Cardiac Surgeon and Associate Chief Clinical Information Officer, commented on the new rating: “I am very proud of the impressive and comprehensive professional approach of the digital team at our HIMSS assessment. It was a real showcase of what can be achieved by clinicians, IT and EPR teams all pulling together.

“The HIMSS recognition also reflects how clinicians and clinical teams at LHCH are increasingly using advanced technologies, clinical systems, data and analytics, as part of everyday clinical practice to support the outstanding care given to our patients.”

Kate Warriner, Chief Digital and Information Officer, added: “Digital Excellence must be the cornerstone if we are to continually improve the care that we provide for our patients in the years ahead. Therefore, whilst we are rightly proud of this achievement, we have ambitions for further pioneering innovation and advancing our use of technology to become a Stage 7 hospital.”

In October 2021, HTN reported on the trust’s roll-out of Isla’s visual technology to support post-surgical wound care. The health tech company’s platform was extended for use on more of the hospital’s wards, following a three-month pilot.

Before then, the trust partnered with an artificial intelligence company to use technology in clinical practice and lung cancer screening. AI solution, Veye Chest, is used to support radiologists analyse routine and screening chest CT scan.